Funded Tech Companies
Intercept Pharmaceuticals
Wondering who provided funding to Intercept Pharmaceuticals? Genextra S.p.A., OrbiMed and private investors joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Intercept Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
10 Hudson Yards 37th Floor
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
For 11 years, Intercept has researched and developed a novel nuclear receptor (FXR). Find out how this science applies to liver and metabolic conditions.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/13/2012
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Pruzanski
Chief Financial Officer
Sandip Kapadia
Chief Operating Officer
Jerome Durso
President
Lisa Bright
VP - General Counsel
Ryan Sullivan
VP - Human Resources
David Ford
VP - R & D
Christian Weyer
Company Investors
- Genextra S.p.A.
- OrbiMed (Jonathan Silverstein)
- Rally Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs